SG11202003147XA - Periodontitis vaccine and related compositions and method of use - Google Patents

Periodontitis vaccine and related compositions and method of use

Info

Publication number
SG11202003147XA
SG11202003147XA SG11202003147XA SG11202003147XA SG11202003147XA SG 11202003147X A SG11202003147X A SG 11202003147XA SG 11202003147X A SG11202003147X A SG 11202003147XA SG 11202003147X A SG11202003147X A SG 11202003147XA SG 11202003147X A SG11202003147X A SG 11202003147XA
Authority
SG
Singapore
Prior art keywords
related compositions
periodontitis
vaccine
periodontitis vaccine
compositions
Prior art date
Application number
SG11202003147XA
Other languages
English (en)
Inventor
Jeffery Fairman
Original Assignee
Vaxcyte Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vaxcyte Inc filed Critical Vaxcyte Inc
Publication of SG11202003147XA publication Critical patent/SG11202003147XA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0216Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/542Mucosal route oral/gastrointestinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/543Mucosal route intranasal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55572Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
SG11202003147XA 2017-10-12 2018-10-11 Periodontitis vaccine and related compositions and method of use SG11202003147XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762571582P 2017-10-12 2017-10-12
PCT/US2018/055496 WO2019075260A1 (en) 2017-10-12 2018-10-11 VACCINE AGAINST PERIODONTITIS AND ASSOCIATED COMPOSITIONS AND METHOD OF USE

Publications (1)

Publication Number Publication Date
SG11202003147XA true SG11202003147XA (en) 2020-05-28

Family

ID=64110091

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202003147XA SG11202003147XA (en) 2017-10-12 2018-10-11 Periodontitis vaccine and related compositions and method of use

Country Status (14)

Country Link
US (2) US10835590B2 (zh)
EP (1) EP3694547A1 (zh)
JP (2) JP7258870B2 (zh)
KR (2) KR102530966B1 (zh)
CN (1) CN111225684A (zh)
AU (1) AU2018347511A1 (zh)
CA (1) CA3078630A1 (zh)
EA (1) EA202090908A1 (zh)
IL (1) IL273690A (zh)
MA (1) MA50363A (zh)
MX (1) MX2020003810A (zh)
PH (1) PH12020550239A1 (zh)
SG (1) SG11202003147XA (zh)
WO (1) WO2019075260A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10835590B2 (en) 2017-10-12 2020-11-17 Vaxcyte, Inc. Periodontitis vaccine and related compositions and methods of use
CN116751292B (zh) * 2023-07-31 2024-05-14 河南大学 牙龈卟啉单胞菌Mfa1单克隆抗体及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59128338A (ja) 1982-12-08 1984-07-24 Kitasato Inst:The 歯周炎予防用ワクチン及びその製法
NZ267291A (en) 1993-05-28 1997-09-22 Chiron Corp Peptide inhibitors of urokinase receptor activity
AUPN627595A0 (en) 1995-10-30 1995-11-23 University Of Melbourne, The Diagnostics and treatments of periodontal disease
WO1997034629A1 (en) 1996-03-22 1997-09-25 University Of Georgia Research Foundation, Inc. Immunogenic compositions comprising porphyromonas gingivalis peptides and methods
US6833262B1 (en) 1999-04-21 2004-12-21 University Of Georgia Research Foundation, Inc. Polypeptide having amidolytic activity for a serpin
AUPQ065299A0 (en) * 1999-05-28 1999-06-24 University Of Sydney, The A method of prophylaxis and treatment and agents useful for same
AUPQ485999A0 (en) * 1999-12-24 2000-02-03 Csl Limited P. gingivalis antigenic composition
US7378101B2 (en) * 2001-12-21 2008-05-27 Pfizer, Inc. Vaccine for periodontal disease
GB0411150D0 (en) 2004-05-19 2004-06-23 Queen Mary & Westfield College Vaccine
BR112012002429A2 (pt) 2009-08-02 2016-11-08 Sanofi Pasteur Ltd polipeptídeos de porphyromonas gingivalis
EP2533794A4 (en) * 2010-02-12 2014-04-23 Univ Sydney PROTEIN DOMAINS AND ASSOCIATED USES
WO2011130544A2 (en) 2010-04-14 2011-10-20 Sutro Biopharma, Inc. Monitoring a dynamic system by liquid chromatography-mass spectrometry
PL2906592T3 (pl) 2012-10-12 2019-07-31 Sutro Biopharma, Inc. Proteolityczna inaktywacja wybranych białek w ekstraktach bakteryjnych dla ulepszonej ekspresji
EP3365027B1 (en) * 2015-10-14 2022-03-30 Research Institute at Nationwide Children's Hospital Hu specific antibodies and their use in inhibiting biofilm
US10835590B2 (en) 2017-10-12 2020-11-17 Vaxcyte, Inc. Periodontitis vaccine and related compositions and methods of use

Also Published As

Publication number Publication date
US20240226259A9 (en) 2024-07-11
CA3078630A1 (en) 2019-04-18
JP2020536925A (ja) 2020-12-17
AU2018347511A8 (en) 2020-06-11
MA50363A (fr) 2020-08-19
US10835590B2 (en) 2020-11-17
US20240131134A1 (en) 2024-04-25
AU2018347511A1 (en) 2020-05-21
KR102530966B1 (ko) 2023-05-15
WO2019075260A1 (en) 2019-04-18
JP2023098935A (ja) 2023-07-11
JP7258870B2 (ja) 2023-04-17
MX2020003810A (es) 2020-08-13
PH12020550239A1 (en) 2021-02-15
US20210361756A1 (en) 2021-11-25
IL273690A (en) 2020-05-31
CN111225684A (zh) 2020-06-02
US11701414B2 (en) 2023-07-18
EA202090908A1 (ru) 2020-10-29
EP3694547A1 (en) 2020-08-19
BR112020006500A2 (pt) 2020-10-13
US20190192645A1 (en) 2019-06-27
KR20230066660A (ko) 2023-05-16
KR20200070302A (ko) 2020-06-17

Similar Documents

Publication Publication Date Title
GB2582482B (en) CASZ compositions and methods of use
IL263287A (en) Neoepitope vaccines and methods of using them
GB2582100B (en) CAS12C Compositions and methods of use
HK1256608A1 (zh) 類黃酮組合物及其使用方法
IL268970A (en) New preparations and methods
ZA201906169B (en) Synthekine compositions and methods of use
HK1248531A1 (zh) 免疫調節組合物及其使用方法
ZA202104969B (en) Compositions comprising 15-hepe and methods of using the same
IL269590A (en) Methods and compositions for reducing immunogenicity
GB202201859D0 (en) Novel methods and compositions
IL276135A (en) Preparations and methods of use
ZA202004531B (en) Compositions containing thymohydroquinone and their method of preparation
ZA202100780B (en) Bismuth-thiol compositions and methods of use
HK1252057A1 (zh) 新穎的使用方法和組合物
IL250853A0 (en) Periodontal gel preparation and method of use
HK1247136A1 (zh) 包含15-hepe的組合物和其使用方法
HK1250345A1 (zh) 包含15-氧代-epa或15-氧代-dgla的組合物及其製備和使用方法
GB201801566D0 (en) Methods and compositions for nanormulsion vaccine formulations
ZA202000502B (en) Cosmetic compositions and methods of use
IL273690A (en) Gingivitis vaccine and related preparations and methods of using it
IL250852A0 (en) Periodontal preparation and method of use
IL274563A (en) Methods of use and preparations containing dolaglutide
HK1248527A1 (zh) 牙科組合物和使用方法
EP3481181A4 (en) PROBIOTIC POULTRY VACCINE COMPOSITIONS AND METHOD FOR USE THEREOF
PL3445730T3 (pl) Makrokompozyty i kompozycje z kamienia i szkła oraz sposoby wytwarzania